BRKR logo

Bruker (BRKR)

Profile

Full Name

Bruker Corporation

Ticker Symbol

BRKR

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 4, 2000

Indexes

Not included

Website

http://www.bruker.com

Employees

11396

Key Details

Price

$39.07(+0.26%)

Market cap

$5.93B(Mid cap)

Last Dividend

$0.05

TTM Dividend yield

0.51%

Annual revenue

$3.37B(+13.56% YoY)

Annual EPS

$0.76(-73.79% YoY)

PE ratio

51.41

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$39.07
BRKR price is $39.07

30-Day Relative Volume

0.66
BRKR 30-day relative volume is 0.66

Price Performance

Price Most recent change

+0.26%
BRKR price was up +0.26% on Apr 25, 2025

Price YTD change

-33.35%
BRKR price is down -33.35% since January 1st

Price 1-year change

-51.52%
BRKR price is down -51.52% year-on-year

Price 3-year change

-33.8%
BRKR price is down -33.8% over the past 3 years

Price Range

Price All-time high

$94.86
BRKR price is currently -58.81% below its historical high of $94.86

Price 3-year low

$34.10
BRKR price is currently +14.57% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.93B
BRKR market capitalization is $5.93 billion

Market cap 3-year change

-32.73%
BRKR market capitalization is down -32.73% over the past 3 years

Market cap All-time high

$13.80B
BRKR market capitalization is currently -57.04% below its historical high of $13.80 billion

Market cap sector rank

89.98%
BRKR market capitalization is higher than 89.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+4.38%
BRKR shares outstanding is up +4.38% year-on-year

Shares Outstanding 3-Year Change

+1.62%
BRKR shares outstanding is up +1.62% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.03
BRKR beta is 1.03

200-day SMA

$56.79
BRKR price is currently -31.20% below its 200-day simple moving average

50-day SMA

$43.99
BRKR price is currently -11.18% below its 50-day simple moving average

RSI

45.87
BRKR 14-day relative strength index is 45.87

Volume

0.66
BRKR 30-day relative volume is 0.66

ATR

$2.02
BRKR average true range is $2.02

10-day Historical Volatility

43.58%
BRKR 10-day historical volatility is 43.58%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.05
BRKR last dividend was $0.05 per share, with an ex-dividend date of March 17, 2025

Next Dividend

-
BRKR next dividend has not yet been announced

Dividend per share

Dividend per share

$0.20
BRKR annual dividend per share is $0.20

Dividend per share Sector Rank

9.2%
BRKR annual dividend per share is higher than 9.2% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
BRKR {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

+25%
BRKR annual dividend per share is up +25% over the past 3 years

Dividend yield

Dividend yield

0.51%
BRKR annual dividend yield is 0.51%

Dividend yield Sector Rank

13.95%
BRKR annual dividend yield is higher than 13.95% of companies in Healthcare sector

Other

Payout ratio

26.70%
BRKR annual payout ratio is 26.70%

Dividends paid

$30.20M
BRKR annual dividends paid is $30.20 million

Free cash flow

$136.00M
BRKR annual free cash flow is $136.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.37B
BRKR annual revenue is $3.37 billion

Revenue Analysts estimate

$3.48B
BRKR annual revenue is currently -3.31% lower than the consensus analysts' forecast

Revenue 1-year change

+13.56%
BRKR annual revenue is up +13.56% year-on-year

Revenue Sector rank

89.42%
BRKR annual revenue is higher than 89.42% of companies in Healthcare sector

EPS

EPS

$0.76
BRKR annual earnings per share is $0.76

EPS Analysts estimate

$2.63
BRKR annual earnings per share is currently -71.06% lower than the consensus analysts' forecast

EPS 1-year change

-73.79%
BRKR annual earnings per share is down -73.79% year-on-year

EPS Sector rank

88.31%
BRKR annual earnings per share is higher than 88.31% of companies in Healthcare sector

Profit

Gross profit

$1.65B
BRKR annual gross profit is $1.65 billion

Gross margin

49.00%
BRKR annual gross profit margin is 49.00%

Operating profit

$253.10M
BRKR annual operating income is $253.10 million

Operating margin

7.52%
BRKR annual operating profit margin is 7.52%

Net income

$113.10M
BRKR annual net profit is $113.10 million

Net margin

3.36%
BRKR annual net profit margin is 3.36%

Expenses

Total expenses

$3.11B
BRKR annual total expenses is $3.11 billion

Operating expenses

$1.40B
BRKR annual total operating expenses is $1.40 billion

Cost of goods sold

$1.72B
BRKR annual cost of goods sold is $1.72 billion

Selling, general & administrative expenses

$893.80M
BRKR annual SGA is $893.80 million

Depreciation and amortization

$183.80M
BRKR annual depreciation & amortization is $183.80 million

Interest expense

$47.90M
BRKR annual interest expense is $47.90 million

Income tax

$91.40M
BRKR annual income tax is $91.40 million

EBIT & EBITDA

EBIT

$245.10M
BRKR annual earnings before interest & taxes is $245.10 million

EBITDA

$428.90M
BRKR annual EBITDA is $428.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.81B
BRKR annual total assets is $5.81 billion

Non current assets

$3.75B
BRKR annual long term assets is $3.75 billion

Current assets

$2.05B
BRKR annual total current assets is $2.05 billion

Cash and cash equivalents

$183.40M
BRKR annual cash & cash equivalents is $183.40 million

Accounts receivable

$565.50M
BRKR annual accounts receivable is $565.50 million

Inventory

$1.07B
BRKR annual inventory is $1.07 billion

Liabilities

Total liabilities

$3.99B
BRKR annual total liabilities is $3.99 billion

Long term liabilities

$2.71B
BRKR annual total long term liabilities is $2.71 billion

Current liabilities

$1.28B
BRKR annual total current liabilities is $1.28 billion

Accounts payable

$234.10M
BRKR annual accounts payable is $234.10 million

Debt

Total debt

$2.25B
BRKR annual total debt is $2.25 billion

Total debt 1-year change

+62.75%
BRKR annual total debt is up +62.75% year-on-year

Long term debt

$2.18B
BRKR annual long term debt is $2.18 billion

Short term debt

$64.60M
BRKR annual short term debt is $64.60 million

Equity & Capital

Shareholders equity

$1.78B
BRKR annual stockholders equity is $1.78 billion

Book value

$1.80B
BRKR annual book value is $1.80 billion

Retained earnings

$2.41B
BRKR annual retained earnings is $2.41 billion

Working capital

$771.90M
BRKR annual working capital is $771.90 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$251.30M
BRKR annual cash flow from operations is $251.30 million

Cash from operations 1-year change

-28.22%
BRKR annual cash flow from operations is down -28.22% year-on-year

Cash from investing

-$1.76B
BRKR annual cash flow from investing activities is -$1.76 billion

Cash from investing 1-year change

-439.05%
BRKR annual cash flow from investing activities is down -439.05% year-on-year

Cash from financing

$1.23B
BRKR annual cash flow from financing activities is $1.23 billion

Cash from financing 1-year change

+735.88%
BRKR annual cash flow from financing activities is up +735.88% year-on-year

CAPEX

CAPEX

$115.30M
BRKR annual capital expenditures is $115.30 million

CAPEX 1-year change

+7.86%
BRKR annual capital expenditures is up +7.86% year-on-year

Free Cash Flow

Free cash flow

$136.00M
BRKR annual free cash flow is $136.00 million

Free cash flow 1-year change

-44.08%
BRKR annual free cash flow is down -44.08% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

49.00%
BRKR annual gross profit margin is 49.00%

Operating margin

7.52%
BRKR annual operating profit margin is 7.52%

Net margin

3.36%
BRKR annual net profit margin is 3.36%

ROA & ROE

ROA

2.25%
BRKR annual return on assets is 2.25%

ROE

7.01%
BRKR annual return on equity is 7.01%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

51.41
BRKR price to earnings ratio is 51.41

PE ratio Sector rank

80.88%
BRKR price to earnings ratio is higher than 80.88% of companies in Healthcare sector

PB Ratio

PB ratio

3.30
BRKR price to book ratio is 3.30

PB ratio Sector rank

73.42%
BRKR price to book ratio is higher than 73.42% of companies in Healthcare sector

PS Ratio

PS ratio

1.76
BRKR price to sales ratio is 1.76

PS ratio Sector rank

38.44%
BRKR price to sales ratio is higher than 38.44% of companies in Healthcare sector

Enterprise value

Enterprise value

$7.87B
BRKR enterprise value is $7.87 billion

Enterprise value Sector rank

90.66%
BRKR enterprise value is higher than 90.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.26
BRKR EV/EBITDA is 18.26

EV/EBITDA Sector rank

90.5%
BRKR EV/EBITDA is higher than 90.5% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.60
BRKR annual current ratio is 1.60

Quick ratio

0.77
BRKR annual quick ratio is 0.77

Leverage

Debt to equity

1.17
BRKR annual debt to equity ratio is 1.17

Interest coverage ratio

5.12
BRKR annual interest coverage ratio is 5.12

Risk & Stability

Piotroski F-Score

4
BRKR piotroski f-score is 4

Altman Z-Score

2.35
BRKR altman z-score is 2.35

Analyst ratings

Recent major analysts updates

Apr 17, 25 Wells Fargo
Overweight
Apr 10, 25 Barclays
Overweight
Apr 7, 25 Citigroup
Buy
Feb 24, 25 Guggenheim
Buy
Feb 14, 25 Stifel
Hold
Feb 14, 25 Barclays
Overweight
Feb 10, 25 Barclays
Overweight
Jan 17, 25 Guggenheim
Buy
Dec 19, 24 Guggenheim
Buy
Dec 13, 24 B of A Securities
Buy

Institutional Ownership

Similar stocks

GH logo
Guardant Health (GH)
STVN logo
Stevanato Group SpA (STVN)
SRPT logo
Sarepta Therapeutics (SRPT)
CRL logo
Charles River Laboratories International (CRL)
BPMC logo
Blueprint Medicines (BPMC)
TFX logo
Teleflex Incorporated (TFX)
MMSI logo
Merit Medical Systems (MMSI)
VRNA logo
Verona Pharma (VRNA)
Telix Pharmaceuticals Limited (TLX)
  • What is the ticker symbol for Bruker?
  • Does Bruker pay dividends?
  • What sector is Bruker in?
  • What industry is Bruker in?
  • What country is Bruker based in?
  • When did Bruker go public?
  • Is Bruker in the S&P 500?
  • Is Bruker in the NASDAQ 100?
  • Is Bruker in the Dow Jones?
  • When was Bruker's last earnings report?
  • When does Bruker report earnings?
  • Should I buy Bruker stock now?

What is the ticker symbol for Bruker?

The ticker symbol for Bruker is NASDAQ:BRKR

Does Bruker pay dividends?

Yes, Bruker pays dividends. The last payment was $0.05, with an ex-dividend date on March 17, 2025

What sector is Bruker in?

Bruker is in the Healthcare sector

What industry is Bruker in?

Bruker is in the Medical Devices industry

What country is Bruker based in?

Bruker is headquartered in United States

When did Bruker go public?

Bruker's initial public offering (IPO) was on August 4, 2000

Is Bruker in the S&P 500?

No, Bruker is not included in the S&P 500 index

Is Bruker in the NASDAQ 100?

No, Bruker is not included in the NASDAQ 100 index

Is Bruker in the Dow Jones?

No, Bruker is not included in the Dow Jones index

When was Bruker's last earnings report?

Bruker's most recent earnings report was on Feb 13, 2025

When does Bruker report earnings?

The next expected earnings date for Bruker is May 7, 2025

Should I buy Bruker stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page